Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc

<< Previous

Bullboard Posts

Next >>

Post by SouthernTierTomon Nov 13, 2020 1:26pm

785 Views

Post# 31896064

Euphas phase 2 trial HALTED at patient 64 of 128 due to....

wait for it....

EXTREME and unexpected efficacy.."it worked too gouda" ; - )

AND because it was aproved in Italia...it was deemed UNETHICAL to complete the trial...

Don't ever post a "case study"..they're useless, they're "hand-picked" ...

Euphas was an example of "translocation" and where PMX works best - IMHO!

Too bad our name never got the mention / inclusion in the Euphas trial ....could have "launched us"...BUT no need to launch until the counter reads "ZERO" - IMHO once more

Nice to have your round though endocrine!